

Exploring his options
Frustrating gMG symptoms meant Michael needed to talk to his doctor about treatment options available for him.
Michael’s story
For most of my life, I had been an active, outgoing, fun-loving co-worker, friend, and husband. But my diagnosis of generalized Myasthenia Gravis (gMG) changed all of that. In February of 2010, my first symptoms became noticeable as I began to struggle slightly with my speech. I was having trouble getting the words out of my mouth and, when I could talk, people were having difficulty understanding me. At the time, I worked as a cashier and greeting people was a regular part of my day, so not being able to communicate clearly was frustrating. I also began to struggle with my activity level and remember going on a short jog that left me very out of breath.
Finding answers
I first sought help from an allergist in hopes of clearing up any congestion. Although my pin test came back completely normal, I started on some allergy medications. I believed I saw a hint of success as my speech problems were intermittent, but nothing was ever fully resolved. Next, I sought treatment from an ear, nose, and throat specialist and had a nasal endoscopy to evaluate my sinus passages. Then, I started seeing a speech therapist who, after a few months, knew this was not a speech problem. I also turned to my rheumatologist, as I also have lupus.
Finally, in May 2011, I went to a neurology specialist. I had yet to find a doctor who knew how to help me, so I remember thinking, “What can this lady do for me?” I actually blew off the first 2 appointments, and when I went to cancel my third appointment, the receptionist said, “Cancel 3 times and you’re done.” Thankfully, that was just what I needed to hear to make me keep my appointment. That day, the neurologist diagnosed me with gMG. I saw my neurologist weekly and followed a treatment regimen. I was relieved to have a diagnosis and to finally know what I was suffering from; however, I still struggled to manage my gMG symptoms.
Continuing to struggle
In March 2015, I hit an all-time low point. I was constantly missing work, was unable to communicate, and didn’t have the energy to get myself ready in the morning. Those were very difficult years as I felt completely isolated and pushed many loved ones away. I felt defeated and thought nobody else could understand what I was going through. gMG impacted my job, put stress on my marriage, and distanced me from my family and friends. Where I had once been the energetic life of the party, I now retreated to my basement, where I found an escape playing video games. I was not the extroverted Michael that those close to me had grown to know and love. One of my lowest moments was when I experienced so much muscle weakness that my wife found me lying on our kitchen floor. She has been my rock, my provider, my constant support, and for her to see me so helpless was upsetting, to say the least.
Starting SOLIRIS
My gMG symptoms were worsening, so my neurologist sent me to see a specialist. Based on my medical history, and because my gMG was anti-AChR antibody positive, I was asked to participate in a clinical trial for SOLIRIS. At that point, I felt like I had nothing to lose, so I started the trial in 2015. First, I had the meningococcal vaccinations. My doctor explained to me that SOLIRIS increases my chance of getting serious and life-threatening meningococcal infections. Meningococcal infections have occurred with patients taking SOLIRIS and may quickly become life-threatening and cause death if not recognized and treated early.
My doctor explained that meningococcal vaccines reduce the risk of meningococcal infection but do not prevent all meningococcal infections. I was advised to call my doctor or get emergency medical care right away if I get any signs and symptoms of a meningococcal infection like headache with nausea or vomiting, headache and fever, headache with a stiff neck or stiff back, fever, fever and a rash, confusion, muscle aches with flu-like symptoms, or if my eyes are sensitive to light. Two weeks later, I would get my infusion. Only later did I learn I was on the placebo part of the trial, not the actual drug.
In January 2016, I started the open-label trial and was actually on SOLIRIS. In 3 months, I started to see results—my talking improved, and I did not need the rest periods due to muscle fatigue/weakness that I had come to expect.
For SOLIRIS, the most common side effect reported for gMG in the trials was muscle and joint (musculoskeletal) pain. I would encourage you to talk to your physician. After the initial 5 weeks of treatment, I continue to get my IV infusions at home every other week by my infusion nurse. My OneSource™ team helps me work with my insurance company. I am on commercial insurance, and my SOLIRIS is covered under my insurance.
Once your SOLIRIS infusion begins, it usually takes about 35 minutes to complete. Serious infusion-related reactions can happen during your SOLIRIS infusion. Tell your doctor or nurse right away if you get any of these symptoms during your SOLIRIS infusion: chest pain; trouble breathing or shortness of breath; swelling of your face, tongue, or throat; feel faint or pass out. If you have an infusion-related reaction to SOLIRIS, your doctor may need to infuse SOLIRIS more slowly, or stop SOLIRIS. Please see additional Important Safety Information for SOLIRIS, including Boxed WARNING regarding serious and life-threatening meningococcal infections, below.
There are things that gMG took away from me that I will never get back—not being able to smile on my wedding day (to this day I only like the way I look in 30 of the 900 wedding pictures), not always being able to kiss my wife, and not being able to communicate with my father, who died of cancer. But today I am returning to what is important to me and what makes me who I am. At work, I am energized by my conversations with both my colleagues and my customers.
Make a difference
Are you interested in becoming a gMG Star? Contact us to share your story so you can help inspire others who are living with gMG.
833-MG-STARS (833-647-8277)
More gMG stories





See available resources
Discover the various tools and resources Alexion has to offer to learn more about anti-AChR antibody-positive gMG.
Learn moreStay connected
Get the latest news and information about anti-AChR antibody-positive gMG and SOLIRIS to help you learn more about your treatment.
Sign up todayWhat is the most important information I should know about SOLIRIS?
SOLIRIS is a medicine that affects your immune system and can lower the ability of your immune system to fight infections.
- SOLIRIS increases your chance of getting serious and life-threatening meningococcal infections that may quickly become life-threatening and cause death if not recognized and treated early.
- You must receive meningococcal vaccines at least 2 weeks before your first dose of SOLIRIS if you are not vaccinated.
- If your doctor decided that urgent treatment with SOLIRIS is needed, you should receive meningococcal vaccination as soon as possible.
- If you have not been vaccinated and SOLIRIS therapy must be initiated immediately, you should also receive two weeks of antibiotics with your vaccinations.
- If you had a meningococcal vaccine in the past, you might need additional vaccination. Your doctor will decide if you need additional vaccination.
- Meningococcal vaccines reduce but do not prevent all meningococcal infections. Call your doctor or get emergency medical care right away if you get any of these signs and symptoms of a meningococcal infection: headache with nausea or vomiting, headache and fever, headache with a stiff neck or stiff back, fever, fever and a rash, confusion, muscle aches with flu-like symptoms, and eyes sensitive to light.
Your doctor will give you a Patient Safety Card about the risk of meningococcal infection. Carry it with you at all times during treatment and for 3 months after your last SOLIRIS dose. It is important to show this card to any doctor or nurse to help them diagnose and treat you quickly.
SOLIRIS is only available through a program called the SOLIRIS REMS. Before you can receive SOLIRIS, your doctor must enroll in the SOLIRIS REMS program; counsel you about the risk of meningococcal infection; give you information and a Patient Safety Card about the symptoms and your risk of meningococcal infection (as discussed above); and make sure that you are vaccinated with the meningococcal vaccine and, if needed, get revaccinated with the meningococcal vaccine. Ask your doctor if you are not sure if you need to be revaccinated.
SOLIRIS may also increase the risk of other types of serious infections. Certain people may be at risk of serious infections with gonorrhea. Certain fungal infections (Aspergillus) may occur if you take SOLIRIS and have a weak immune system or a low white blood cell count.
Who should not receive SOLIRIS?
Do not receive SOLIRIS if you have a meningococcal infection or have not been vaccinated against meningitis infection unless your doctor decides that urgent treatment with SOLIRIS is needed.
Before you receive SOLIRIS, tell your doctor about all of your medical conditions, including if you: have an infection or fever, are pregnant or plan to become pregnant, and are breastfeeding or plan to breastfeed. It is not known if SOLIRIS will harm your unborn baby or if it passes into your breast milk.
Tell your doctor about all the vaccines you receive and medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements which could affect your treatment. It is important that you have all recommended vaccinations before you start SOLIRIS, receive 2 weeks of antibiotics if you immediately start SOLIRIS, and stay up-to-date with all recommended vaccinations during treatment with SOLIRIS.
What are the possible side effects of SOLIRIS?
SOLIRIS can cause serious side effects including serious infusion-related reactions. Tell your doctor or nurse right away if you get any of these symptoms during your SOLIRIS infusion: chest pain, trouble breathing or shortness of breath, swelling of your face, tongue, or throat, and feel faint or pass out. If you have an infusion-related reaction to SOLIRIS, your doctor may need to infuse SOLIRIS more slowly, or stop SOLIRIS.
The most common side effects in people with gMG treated with SOLIRIS include: muscle and joint (musculoskeletal) pain.
Tell your doctor about any side effect that bothers you or that does not go away. These are not all the possible side effects of SOLIRIS. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch, or call 1-800-FDA-1088.
INDICATION
What is SOLIRIS?
SOLIRIS is a prescription medicine used to treat adults with a disease called generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. It is not known if SOLIRIS is safe and effective in children with gMG.
Please see the full Prescribing Information and Medication Guide for SOLIRIS, including Boxed WARNING regarding serious and life-threatening meningococcal infections.
What is the most important information I should know about SOLIRIS?
SOLIRIS is a medicine that affects your immune system and can lower the ability of your immune system to fight infections.
- SOLIRIS increases your chance of getting serious and life-threatening meningococcal infections that may quickly become life-threatening and cause death if not recognized and treated early.
- You must receive meningococcal vaccines at least 2 weeks before your first dose of SOLIRIS if you are not vaccinated.
- If your doctor decided that urgent treatment with SOLIRIS is needed, you should receive meningococcal vaccination as soon as possible.
- If you have not been vaccinated and SOLIRIS therapy must be initiated immediately, you should also receive two weeks of antibiotics with your vaccinations.
- If you had a meningococcal vaccine in the past, you might need additional vaccination. Your doctor will decide if you need additional vaccination.
- Meningococcal vaccines reduce but do not prevent all meningococcal infections. Call your doctor or get emergency medical care right away if you get any of these signs and symptoms of a meningococcal infection: headache with nausea or vomiting, headache and fever, headache with a stiff neck or stiff back, fever, fever and a rash, confusion, muscle aches with flu-like symptoms, and eyes sensitive to light.
Your doctor will give you a Patient Safety Card about the risk of meningococcal infection. Carry it with you at all times during treatment and for 3 months after your last SOLIRIS dose. It is important to show this card to any doctor or nurse to help them diagnose and treat you quickly.
SOLIRIS is only available through a program called the SOLIRIS REMS. Before you can receive SOLIRIS, your doctor must enroll in the SOLIRIS REMS program; counsel you about the risk of meningococcal infection; give you information and a Patient Safety Card about the symptoms and your risk of meningococcal infection (as discussed above); and make sure that you are vaccinated with the meningococcal vaccine and, if needed, get revaccinated with the meningococcal vaccine. Ask your doctor if you are not sure if you need to be revaccinated.
SOLIRIS may also increase the risk of other types of serious infections. Certain people may be at risk of serious infections with gonorrhea. Certain fungal infections (Aspergillus) may occur if you take SOLIRIS and have a weak immune system or a low white blood cell count.
Who should not receive SOLIRIS?
Do not receive SOLIRIS if you have a meningococcal infection or have not been vaccinated against meningitis infection unless your doctor decides that urgent treatment with SOLIRIS is needed.
Before you receive SOLIRIS, tell your doctor about all of your medical conditions, including if you: have an infection or fever, are pregnant or plan to become pregnant, and are breastfeeding or plan to breastfeed. It is not known if SOLIRIS will harm your unborn baby or if it passes into your breast milk.
Tell your doctor about all the vaccines you receive and medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements which could affect your treatment. It is important that you have all recommended vaccinations before you start SOLIRIS, receive 2 weeks of antibiotics if you immediately start SOLIRIS, and stay up-to-date with all recommended vaccinations during treatment with SOLIRIS.
What are the possible side effects of SOLIRIS?
SOLIRIS can cause serious side effects including serious infusion-related reactions. Tell your doctor or nurse right away if you get any of these symptoms during your SOLIRIS infusion: chest pain, trouble breathing or shortness of breath, swelling of your face, tongue, or throat, and feel faint or pass out. If you have an infusion-related reaction to SOLIRIS, your doctor may need to infuse SOLIRIS more slowly, or stop SOLIRIS.
The most common side effects in people with gMG treated with SOLIRIS include: muscle and joint (musculoskeletal) pain.
Tell your doctor about any side effect that bothers you or that does not go away. These are not all the possible side effects of SOLIRIS. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch, or call 1-800-FDA-1088.
INDICATION
What is SOLIRIS?
SOLIRIS is a prescription medicine used to treat adults with a disease called generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. It is not known if SOLIRIS is safe and effective in children with gMG.
Please see the full Prescribing Information and Medication Guide for SOLIRIS, including Boxed WARNING regarding serious and life-threatening meningococcal infections.